Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

Journal of Neurology, Neurosurgery & PsychiatryLevetiracetam vs. Fosphenytoin as a Second-line Treatment After Diazepam for Adult Convulsive Status Epilepticus: A Multicenter Non-inferiority Randomized Control Trial

In this multicenter study, adult patients with status epilepticus were randomized into levetiracetam (LEV) or fosphenytoin (FPHT) as a second-line treatment after diazepam. The authors conclude that LEV may be recommended as a second-line treatment for SE along with phenytoin/FPHT.

Was this Essential useful?

More Essentials From

ACP Internist
Annals of Internal Medicine
British Medical Journal
Cancer Therapy Advisor
Cleveland Clinic Journal of Medicine
Clinical Advisor
Consultant360
Dana-Farber Cancer Institute
Healthgrades for Professionals
MDLinx
Neurology Advisor
OBR Oncology
Oncology Learning Network
Psych Congress Network
Psychiatrist.com
The Epoch Times
The New England Journal of Medicine
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form